According to The Insight Partners’ research, the global Colostrum Market is slated to accumulate US$ 1,987.87 million by 2027 from US$ 1,418.90 million in 2018, expanding at 3.9% CAGR from 2019 to 2027. The role of colostrum in animal husbandry and the benefits of colostrum for athletes are the crucial factors credited for this growth.

 

Colostrum is the first milk that is obtained after the parturition, which provides a complete diet for the neonate. Colostrum contains a large amount of Gama globulins, antibodies that are produced by the cows against the antigens to encounter many disease-producing organisms. Also, colostrum has a higher amount of vitamin A and minerals that are vital to battle diseases. Ingestion of these elements through colostrum considerably increases survivability and provide an umbrella of passive immunity to calves.

As per the research studies, the calf obtains a sufficient level of antibodies from colostrum that are less disposed to sickness and death caused by common infectious diseases such as diarrhea, septicaemia, and respiratory illness. Calf consumes lactose and fat from colostrum to prompt heat production and maintain persistent body temperature. The passive transfer of immunity via colostrum to neonate's calf is majorly dependent factors such as the quantity of colostrum, quality of colostrum, and timing. Thus, the crucial role of colostrum in animal husbandry will likely aid market augmentation.

Leading players profiled in the global colostrum market report are The Saskatoon Colostrum Company Ltd.; Biochem Zusatzstoffe Handels- und Produktionsges. mbH; Dairy Tech, Inc.; ImmuCell Corporation; Fonterra Co-operative Group Limited; Immuno-Dynamics, Inc.; European Colostrum Industry; Pantheryx, Inc.; ColoQuick International; and Biostrum Nutritech Private Limited.

Browse Complete Report @ https://www.theinsightpartners.com/reports/colostrum-market

Additionally, bovine colostrum provides an alternative to traditional athletic performance supplements that is available for athletes of all skill levels and all ages. It is an all-natural super food that contains growth hormones, which are biologically transferrable for human use. The large quantity of insulin-like growth factor (IGF-1) held in colostrum makes it an ideal supplement for athletes thus resulting in market expansion. On the other hand, stringent regulations regarding the use of bovine colostrum for infant formula will likely hinder market proliferation over the forecast timeframe.

Based on product gamut, the global colostrum market is split into whole, skimmed, and specialty colostrum powder. Of these, the whole colostrum powder segment held 47.1% of the market share in 2018. The segment was assessed at US$ 689.58 million in 2018 and is slated to accrue US$ 962.58 million by 2027, growing at 3.9% CAGR over 2019–2027.

As per application scope, the market is arrayed into animal feed, nutritional supplement, and others. Among these, the nutritional supplementation segment captured 68.87% of the market share in 2018. The segment was evaluated at US$ 1,008.20 million in 2018 and is estimated to garner US$ 1,444.07 million by 2027, augmenting at 4.2% CAGR from 2019 to 2027.

From the regional frame of reference, Asia Pacific held a major share in the global colostrum market in 2018. The region was appraised at US$ 553.21 million in 2018 and is projected to amass US$ 804.69 million by 2027, expanding at a stellar growth rate of 4.4% CAGR between 2019 and 2027.

•             In September 2019, ImmuCell Corporation entered into a lease agreement for a facility to expand first defense production capacity. The property is located near the company’s previous facility at 56 evergreen drive in Portland, Maine.

•             In June 2018, PanTheryx Inc., a medical nutrition company focused on improving global health, unveiled its newly expanded 112,000 sq. ft. production facility in Phoenix. PanTheryx has doubled the company’s production capacity to meet the growing global demand for colostrum.

•             In March 2018, Fonterra launched cutting edge technology taking health and safety into the 22nd century. The new technology will place Fonterra at the forefront of global health and safety innovation.

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense, Food & beverage, Chemical and Materials, Semiconductors etc.

 Contact Us:

Call: +1-646-491-9876

Email: sales@theinsightpartners.com